RankingsPricing
  1. JP-listed companies
  2. PhoenixBio Co.,Ltd.
  3. Financials
  4. Stockholders' equity

PhoenixBio Co.,Ltd.JP:6190

Market cap
¥1.9B
P/E ratio
17.7x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 20251,365-24.04%
Mar 31, 20241,798+18.70%
Mar 31, 20231,514+82.87%
Mar 31, 2022828-24.30%
Mar 31, 20211,094-5.84%
Mar 31, 20201,162-24.69%
Mar 31, 20191,543-16.94%
Mar 31, 20181,857-11.71%
Mar 31, 20172,104+6.50%
Mar 31, 20161,975+86.91%
Mar 31, 20151,057+17.39%
Mar 31, 2014900

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)